Clinical Trials List
2009-12-01 - 2011-12-31
Phase II
Terminated6
ICD-10C92.00
Acute myeloblastic leukemia, not having achieved remission
ICD-10C92.02
Acute myeloblastic leukemia, in relapse
ICD-10C92.40
Acute promyelocytic leukemia, not having achieved remission
ICD-10C92.42
Acute promyelocytic leukemia, in relapse
ICD-10C92.50
Acute myelomonocytic leukemia, not having achieved remission
ICD-10C92.52
Acute myelomonocytic leukemia, in relapse
ICD-10C92.60
Acute myeloid leukemia with 11q23-abnormality not having achieved remission
ICD-10C92.62
Acute myeloid leukemia with 11q23-abnormality in relapse
ICD-10C92.A0
Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
ICD-10C92.A2
Acute myeloid leukemia with multilineage dysplasia, in relapse
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9205.00
Acute myeloid leukemia, without mention of remission
-
Trial Applicant
QPS
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
90 participants
